The role of Neurotransmitters in the Genesis of Uremic Encephalopathy

Abstract

To classify the influence of neurotransmitters in the genesis of uremic encephalopathy we studied cerebrospinal fluid (CSF) and plasma (P) amino acid (AA) concentration, in patients undergoing various dialytic treatments (hemodialysis = HD, intermittent and continuous peritoneal dialysis = IPD and CAPD).

HD causes a significant decrease in CSF/P ratios of branched chain AA (BCAA) and a significant increase in CSF Glycine/Valine ratio, suggesting an augmented brain uptake of Glycine at detriment of Valine. In IPD the general trend of Aromatic AA/BCAA ratio suggests a preferentilal transport of Aromatic AA through the blood brain barrier. The differences between IPD and HD are confirmed by data concerning metabolites of Serotonin and Dopamine: CSF concentrations of 5-Hydroxyndoleacetic acid and Homovanillic acid are low in HD but high in IPD.

So, a reduced (in HD) and an increased (in IPD) activity of monoamine systems could be at the basis of some neurological disturbances appearing in uremia.

Keywords

Amino acids Monoamines Neurotransmitters Dialysis Uremia Encephalopathy

Get full access to this article

View all access options for this article.

References

Alvestrand

, Furst

, Bergstrom

: Plasma and muscle free AA in uremia: influence of nutrition with amino acids. Clin. Nephrol. 18: 297, 1982.

Biasioli

, Chiaramonte

, Fabris

, Feriani

, Pisani

, Valli

, Dalla Fior

, D'Andrea

, La Greca

: Neurotransmitters imbalance in plasma and cerebrospinal fluid during dialytic treatment. Trans. A.S.A.I.O. 1983; XXIX, 44.

DeFerrari

, Garibotto

, Robaudo

, Ghiggeri

G.M.

, Tizianello

: Brain metabolism of amino acids and ammonia in patients with chronic renal insufficiency. Kidney Int. 20: 505, 1981.

Freeman

R.B.

, Sheff

M.F.

, Maher

J.F.

, Schreiner

G.E.

: The blood cerebral fluid barrier in uremia. Ann. Int. Med. 56: 233, 1962.

Funder

, Wieth

J.O.

: Changes in cerebrospinal fluid composition following hemodialysis. Scand. J. Clin. Labor. 19: 302, 1967.

Giordano

, De Pascale

, De Santo

N.G.

, Esposito

, Cirilli

, Stangherlin

: Disorder in the metabolism of some amino acids in uremia. In: Proc. of the 4th Int. Congress of Nephrol. S. Karger: Basel, 196, 1970.

Gulyassy

P.F.

, Peters

J.H.

, Lin

S.C.

, Ryan

P.M.

: Hemodialysis and plasma amino acid composition in chronic renal failure. Am. J. Clin. Nutr. 21: 565, 1968.

Iversen

L.L.

: Neurotransmitters and CNE disease. Lancet 2: 914, 1982.

Marsden

C.D.

: Basal ganglia disease. Lancet 2: 1141, 1982.

10.

Mc Gale

E.H.F.

, Pye

I.F.

, Stonier

, Hutchinson

E.C.

, Aber

G.M.

: Studies of the interrelationship between cerebrospinal fluid and plasma amino acid concentration in normal individuals. J. Neurochem. 29: 291, 1977.

11.

Mc Gale

E.H.F.

, Pye

I.F.

, Corston

, Stonier

, Hutchinson

E.C.

, Aber

G.M.

: The effect of hemodialysis on cerebrospinal fluid and plasma amino acids. Clin. Chim. Acta 92: 73, 1979.

12.

Pardrige

W.M.

, Oldendorf

W.H.

: Transport of metabolic substrates through the blood brain barrier. J. Neurochem. 5: 28, 1977.

13.

Pye

I.F.

, Mc Gale

E.H.F.

, Stonier

, Hutchinson

E.C.

, Aber

G.M.

: Studies of cerebrospinal fluid and plasma amino acid in patients with steady state chronic renal failure. Clin. Chim. Acta 92: 65, 1979.

14.

Van Praag

H.M.

: Depression. Lancet 2: 1259, 1982.

15.

Young

G.A.

, Parsons

F.M.

: The effect of peritoneal dialysis upon the amino acids and other nitrogen compounds in the blood and dialysates from patients with renal failure. Cli. Science 37: 1, 1969.